Functional Outcomes in Patients with Human Papillomavirus‐Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy

Abstract

ObjectivesTo describe swallowing and feeding‐tube outcomes in patients with high‐risk oropharyngeal cancer treated with trimodality therapy (TMT), including transoral robotic surgery (TORS) and adjuvant chemoradiotherapy.MethodsA chart review was conducted on patients with HPV+ OPSCC receiving TMT with TORS at an academic medical center from March 2010 to March 2021. Data collected included demographics, treatment, feeding tube placement, functional oral intake scale (FOIS) scores, and swallowing‐language pathology (SLP) evaluations.ResultsA total of 255 patients met selection criteria (mean age 61 years, 88% male). Following intraoperative nasogastric tube (NG) placement, 31% remained NG tube dependent after 3 weeks. A gastrostomy tube was placed in 19% of patients, and at 1 year after end‐of‐treatment (EOT), 3.5% overall remained tube‐dependent. Mean FOIS scores were 6.9 (SD = 0.3) at pre‐operative visit, 2.6 (1.8) at first post‐operative visit, and 5.5 (1.5) after EOT. In the subset of patients with follow‐up longer than 2 years (n = 118), the mean FOIS was 6.1 (SD = 1.3) at most recent visit. Clinical signs of aspiration/penetration were suspected on SLP evaluation in 18% of patients. These patients were subsequently evaluated with fiberoptic endoscopic evaluation of swallowing (FEES) and/or barium swallow study, which confirmed signs of aspiration in 2.7% of patients overall. Delayed NG tube removal after 3 weeks was predictive of (1) gastrostomy tube requirement and (2) clinical signs of aspiration on an SLP visit after EOT.ConclusionsFavorable functional and feeding‐tube outcomes are demonstrated in patients with HPV‐associated OPSCC undergoing TMT. In this single‐institution study, we found low rates of long‐term feeding tube dependence and high median FOIS following treatment. Review of routine SLP visits provides a detailed and easily accessible means for assessing swallowing function in this cohort.Level of Evidence4 Laryngoscope, 2023